VIROMED MEDICAL NA O.N. - Asset Resilience Ratio
VIROMED MEDICAL NA O.N. (VME) has an Asset Resilience Ratio of 0.03% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See VIROMED MEDICAL NA O.N. working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2024–2025)
This chart shows how VIROMED MEDICAL NA O.N.'s Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see VIROMED MEDICAL NA O.N. total assets.
Liquid Assets Composition Over Time
This chart breaks down VIROMED MEDICAL NA O.N.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read VIROMED MEDICAL NA O.N. balance sheet liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €4.51K | 0.03% |
| Total Liquid Assets | €4.51K | 0.03% |
Asset Resilience Insights
- Limited Liquidity: VIROMED MEDICAL NA O.N. maintains only 0.03% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
VIROMED MEDICAL NA O.N. Industry Peers by Asset Resilience Ratio
Compare VIROMED MEDICAL NA O.N.'s asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
TransMedics Group Inc
NASDAQ:TMDX |
Medical Devices | 0.00% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.84% |
|
Novocure Ltd
NASDAQ:NVCR |
Medical Devices | 43.72% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 34.37% |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581 |
Medical Devices | 18.80% |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580 |
Medical Devices | 10.74% |
|
Nanjing Medlander Medical Technology Co. Ltd. A
SHG:688273 |
Medical Devices | 34.29% |
Annual Asset Resilience Ratio for VIROMED MEDICAL NA O.N. (2024–2025)
The table below shows the annual Asset Resilience Ratio data for VIROMED MEDICAL NA O.N..
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.03% | €4.51K ≈ $5.28K |
€13.91 Million ≈ $16.27 Million |
+0.00pp |
| 2024-12-31 | 0.03% | €3.78K ≈ $4.42K |
€13.40 Million ≈ $15.66 Million |
-- |
About VIROMED MEDICAL NA O.N.
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology. The company was formerly known as Fonterelli SPAC2 AG. Viromed Medical AG was incorporated in 2021 and is based in Pinneberg, Germany.